[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2570597T3 - Proceso e intermedios para la preparación de Salmeterol - Google Patents

Proceso e intermedios para la preparación de Salmeterol

Info

Publication number
ES2570597T3
ES2570597T3 ES06794800T ES06794800T ES2570597T3 ES 2570597 T3 ES2570597 T3 ES 2570597T3 ES 06794800 T ES06794800 T ES 06794800T ES 06794800 T ES06794800 T ES 06794800T ES 2570597 T3 ES2570597 T3 ES 2570597T3
Authority
ES
Spain
Prior art keywords
salmeterol
intermediates
preparation
ether
nai
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06794800T
Other languages
English (en)
Inventor
Vinayak G Gore
Avinash C Gaikwad
M Gadakar
V K Shukla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Original Assignee
Generics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd filed Critical Generics UK Ltd
Application granted granted Critical
Publication of ES2570597T3 publication Critical patent/ES2570597T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/16—Preparation of ethers by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un proceso para preparar un éter (5), que comprende la etapa de: (a) hacer reaccionar 4-fenil-1-butanol (3) y X-(CH2)6-X (4) en presencia de un agente de transferencia de fases y NaI para obtener el éter (5), en donde X son de forma independiente grupos salientes:**Fórmula**
ES06794800T 2005-10-17 2006-10-17 Proceso e intermedios para la preparación de Salmeterol Active ES2570597T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1298MU2005 2005-10-17
IN827MU2006 2006-05-31
PCT/GB2006/003857 WO2007045857A1 (en) 2005-10-17 2006-10-17 Novel process

Publications (1)

Publication Number Publication Date
ES2570597T3 true ES2570597T3 (es) 2016-05-19

Family

ID=37716215

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06794800T Active ES2570597T3 (es) 2005-10-17 2006-10-17 Proceso e intermedios para la preparación de Salmeterol

Country Status (8)

Country Link
US (1) US8648214B2 (es)
EP (2) EP1937626B1 (es)
JP (1) JP5599974B2 (es)
AU (1) AU2006303124B2 (es)
CA (2) CA2838520C (es)
ES (1) ES2570597T3 (es)
PL (1) PL1937626T3 (es)
WO (1) WO2007045857A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080319086A1 (en) * 2007-06-20 2008-12-25 Protia, Llc Deuterium-enriched salmeterol
CN101712622B (zh) * 2009-11-10 2012-10-03 浙江万里学院 抗哮喘药物沙美特罗的制备方法
WO2012032546A2 (en) 2010-09-08 2012-03-15 Cadila Healthcare Limited Process for the preparation of salmeterol and its intermediates
CN102993031B (zh) * 2011-09-19 2014-03-26 北京桑普生物化学技术有限公司 一种制备芳基多氧烷基季铵类化合物的方法
WO2015012271A1 (ja) * 2013-07-25 2015-01-29 日産化学工業株式会社 複素環化合物の製造方法
CN103641727A (zh) * 2013-12-02 2014-03-19 山东永泰化工有限公司 一种羟萘酸沙美特罗的制备方法
US9447067B2 (en) 2014-10-03 2016-09-20 Amphastar Pahmaceuticals, Inc. Method of preparing intermediate of salmeterol
WO2016142582A1 (en) 2015-03-11 2016-09-15 Fermion Oy Process for the preparation of crystalline salmeterol and its xinafoate salt
WO2017168431A1 (en) * 2016-03-30 2017-10-05 Davuluri Ramamohan Rao Process for the preparation of salmeterol xinafoate

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468881A (en) * 1966-08-15 1969-09-23 Upjohn Co Allylic amines
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US4952729A (en) 1986-09-05 1990-08-28 Schering-Plough Corp. Intermediates in the preparation of alpha1(((1,1-dimethylethyl) amino) methyl)-4-hydroxy-1,3-benzenedimethanol
US5011993A (en) 1986-09-05 1991-04-30 Schering Corporation Method for the preparation of α1 [[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol
JPH03133946A (ja) * 1989-10-10 1991-06-07 Glaxo Group Ltd フェンエタノールアミン化合物
JPH1112219A (ja) * 1997-06-24 1999-01-19 Chemprokasei Kaisha Ltd ポリヒドロキシベンゾフェノン類の部分アルキル化法
DE69940423D1 (de) * 1998-01-30 2009-04-02 Daiso Co Ltd Verfahren zur herstellung von butantriol-derivaten
ES2142771B1 (es) 1998-09-28 2001-01-01 Vita Invest Sa Nuevos derivados de la 6-(4-fenil-butoxi) hexilamina y procedimiento para la obtencion de salmeterol.
JP2001247517A (ja) * 2000-03-07 2001-09-11 Sumitomo Chem Co Ltd 溶液中のα−ハロエステル化合物の低減方法
FR2807039A1 (fr) * 2000-03-31 2001-10-05 Adir NOUVEAU PROCEDE DE PREPARATION DE LA 11-AMINO-3-CHLORO-6,11- DIHYDRO-5,5-DIOXO-6-METHYL-DIBENZO[c,f][1,2]-THIAZEPINE ET APPLICATION A LA SYNTHESE DE LA TIANEPTINE
GB0014546D0 (en) * 2000-06-14 2000-08-09 Glaxo Group Ltd A novel process
US6835857B2 (en) 2002-03-05 2004-12-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the manufacture of 4-(6-bromohexyloxy)-butylbenzene
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate

Also Published As

Publication number Publication date
EP1937626A1 (en) 2008-07-02
CA2838520A1 (en) 2007-04-26
WO2007045857A1 (en) 2007-04-26
CA2838520C (en) 2017-02-21
JP5599974B2 (ja) 2014-10-01
AU2006303124B2 (en) 2013-03-28
CA2625337A1 (en) 2007-04-26
PL1937626T3 (pl) 2016-08-31
AU2006303124A1 (en) 2007-04-26
US20080262267A1 (en) 2008-10-23
EP1937626B1 (en) 2016-02-17
US8648214B2 (en) 2014-02-11
CA2625337C (en) 2014-03-18
JP2009513578A (ja) 2009-04-02
EP2641893A1 (en) 2013-09-25

Similar Documents

Publication Publication Date Title
ES2570597T3 (es) Proceso e intermedios para la preparación de Salmeterol
ES2538103T3 (es) Método de síntesis mejorado para la síntesis de pirfenidona
UY29375A1 (es) 5-alcoxialquil-6-alquil-7-amino-azolopirimidinas, un procedimiento para su obtención y el uso de las mismas para combatir hongos nocivos,así como productos que las contienen.
CR11492A (es) Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i
UY32611A (es) Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
BRPI0506438A (pt) aerogéis de ormosil contendo polimetacrilato ligado por silìcio
PA8549301A1 (es) Compuestos heterobiciclicos sustituidos con triamida
WO2008128934A3 (en) Fluorinated dyes and their use in electrophoretic display devices
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
BRPI0415855A (pt) processo para preparação de ésteres de ácido 2-dihalogenacil-3-amino-acrìlico e ésteres de ácido 3-dihalogeno-metil-pirazol-4-carboxìlico
UY30292A1 (es) Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor b(beta)2 adrenérgico
CR10157A (es) Compuestos químicos
CY1122416T1 (el) Φαρμακα τα οποια περιεχουν κρυσταλλικες τροποποιησεις (1r,2r)-3-(3-δimeθyλamino-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
BRPI0821362A2 (pt) Composto, uso do mesmo, composição, semente, método para controlar fungos fitopatogênicos, medicamento, e, processos para preparar um antimicótico e para preparar compostos
CY1109737T1 (el) Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγομελατινης
BRPI0821708A2 (pt) Processo para obter fluorometil 1,1,1,3,3,3-hexa-fluorisopropil éter purificado
ES2603227T3 (es) Proceso para la preparación de compuestos cetólidos
BRPI0622035A2 (pt) Processo para preparação do éter clorometil 2,2,2-trifluoro-1-(trifluorometil) etílico
MY165487A (en) Process for preparing a polyol ether
CL2012001742A1 (es) Uso de tp3 como agente de acoplamiento para la prepa racion de un intermediario de combretastatina.
AR048235A1 (es) Un procedimiento para la sintesis de (7-metoxi-3,4-dihidro-1-naftalenil)acetonitrilo y su aplicacion en la sintesis de agomelatina
CR9208A (es) Procesos para la preparacion de alcoholes de aminoetoxibencilo
MX2009011607A (es) Alquiloxi-eteres novedosos y alcoxilatos de los mismos.
AR050709A1 (es) Metodo para preparar irbesartan e intermediarios del mismo